A carregar...
A Novel Gene Underlies Bleomycin-Response Variation in Caenorhabditis elegans
Bleomycin is a powerful chemotherapeutic drug used to treat a variety of cancers. However, individual patients vary in their responses to bleomycin. The identification of genetic differences that underlie this response variation could improve treatment outcomes by tailoring bleomycin dosages to each...
Na minha lista:
| Publicado no: | Genetics |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Genetics Society of America
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6707474/ https://ncbi.nlm.nih.gov/pubmed/31171655 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1534/genetics.119.302286 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|